Imputing the Number of Responders from the Mean and Standard Deviation of CGI-Improvement in Clinical Trials Investigating Medications for Autism Spectrum Disorder

dc.contributor.author Siafis, Spyridon
dc.contributor.author Rodolico, Alessandro
dc.contributor.author Çiray, Oğulcan
dc.contributor.author Murphy, Declan G.m.
dc.contributor.author Parellada-Redondo, Mara José
dc.contributor.author Arango, Celso
dc.contributor.author Leucht, Stefan
dc.date.accessioned 2025-09-15T16:30:05Z
dc.date.available 2025-09-15T16:30:05Z
dc.date.issued 2021
dc.description.abstract Introduction: Response to treatment, according to Clinical Global Impression-Improvement (CGI-I) scale, is an easily interpretable outcome in clinical trials of autism spectrum disorder (ASD). Yet, the CGI-I rating is sometimes reported as a continuous outcome, and converting it to dichotomous would allow meta-analysis to incorporate more evidence. Methods: Clinical trials investigating medications for ASD and presenting both dichotomous and continuous CGI-I data were included. The number of patients with at least much improvement (CGI-I ≤ 2) were imputed from the CGI-I scale, assuming an underlying normal distribution of a latent continuous score using a primary threshold θ = 2.5 instead of θ = 2, which is the original cut-off in the CGI-I scale. The original and imputed values were used to calculate responder rates and odds ratios. The performance of the imputation method was investigated with a concordance correlation coefficient (CCC), linear regression, Bland–Altman plots, and subgroup differences of summary estimates obtained from random-effects meta-analysis. Results: Data from 27 studies, 58 arms, and 1428 participants were used. The imputation method using the primary threshold (θ = 2.5) had good performance for the responder rates (CCC = 0.93 95% confidence intervals [0.86, 0.96]; β of linear regression = 1.04 [0.95, 1.13]; bias and limits of agreements = 4.32% [−8.1%, 16.74%]; no subgroup differences χ2 = 1.24, p-value = 0.266) and odds ratios (CCC = 0.91 [0.86, 0.96]; β = 0.96 [0.78, 1.14]; bias = 0.09 [−0.87, 1.04]; χ2 = 0.02, p-value = 0.894). The imputation method had poorer performance when the secondary threshold (θ = 2) was used. Discussion: Assuming a normal distribution of the CGI-I scale, the number of responders could be imputed from the mean and standard deviation and used in meta-analysis. Due to the wide limits of agreement of the imputation method, sensitivity analysis excluding studies with imputed values should be performed. © 2021 Elsevier B.V., All rights reserved. en_US
dc.identifier.doi 10.3390/brainsci11070908
dc.identifier.issn 2076-3425
dc.identifier.scopus 2-s2.0-85110914396
dc.identifier.uri https://doi.org/10.3390/brainsci11070908
dc.identifier.uri https://hdl.handle.net/20.500.12514/9286
dc.language.iso en en_US
dc.publisher MDPI AG en_US
dc.relation.ispartof Brain Sciences en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.subject Continuous Outcomes en_US
dc.subject Dichotomous Outcomes en_US
dc.subject Meta-Analysis en_US
dc.subject Response en_US
dc.title Imputing the Number of Responders from the Mean and Standard Deviation of CGI-Improvement in Clinical Trials Investigating Medications for Autism Spectrum Disorder
dc.type Article en_US
dspace.entity.type Publication
gdc.author.scopusid 57191500943
gdc.author.scopusid 57195995122
gdc.author.scopusid 57219228164
gdc.author.scopusid 7404062227
gdc.author.scopusid 14040702000
gdc.author.scopusid 6508338058
gdc.author.scopusid 6508338058
gdc.description.department Artuklu University en_US
gdc.description.departmenttemp [Siafis] Spyridon, Department of Psychiatry and Psychotherapy, TUM Fakultät für Medizin, Munich, Germany; [Rodolico] Alessandro, Università degli Studi di Catania, Scuola di Medicina, Catania, Italy; [Çiray] Oğulcan, Department of Child and Adolescent Psychiatry, Mardin State Hospital, Artuklu, Mardin, Turkey; [Murphy] Declan G.m., Department of Forensic and Neurodevelopmental Sciences, King's College London, London, United Kingdom; [Parellada-Redondo] Mara José, Department of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Marañón, Madrid, Spain, Universidad Complutense de Madrid, Facultad de Medicina, Madrid, Spain; [Arango] Celso, Department of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Marañón, Madrid, Spain, Universidad Complutense de Madrid, Facultad de Medicina, Madrid, Spain; [Leucht] Stefan, Department of Psychiatry and Psychotherapy, TUM Fakultät für Medizin, Munich, Germany en_US
gdc.description.issue 7 en_US
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q3
gdc.description.volume 11 en_US
gdc.description.wosquality Q3

Files